Mixed lineage kinase activity of indolocarbazole analogues

Area of Science:

• Medicinal Chemistry
• Molecular Pharmacology
• Drug Discovery

Background:

• Mixed lineage kinases (MLKs) are key regulators of stress-induced signaling pathways.
• Indolocarbazole K-252a serves as a structural scaffold for developing kinase inhibitors.
• Targeting MLK1-3 is a potential therapeutic strategy for various diseases.

Purpose of the Study:

• To synthesize and evaluate novel analogues of K-252a as MLK1-3 inhibitors.
• To assess the in vitro and in vivo biological activities of promising compounds.

Main Methods:

• Synthesis of K-252a analogues with 3,9-bis-alkylthiomethyl modifications.
• In vitro enzyme inhibition assays for MLK1-3 activity.
• In vitro and in vivo studies to evaluate survival-promoting effects.

Main Results:

• Addition of 3,9-bis-alkylthiomethyl groups yielded potent and selective MLK inhibitors.
• Compound 16 (bis-isopropylthiomethyl-K-252a, CEP-11004/KT-8138) exhibited significant MLK1-3 inhibitory activity.
• Compound 16 demonstrated notable in vitro and in vivo survival-promoting effects.

Conclusions:

• Novel K-252a analogues, particularly bis-isopropylthiomethyl-K-252a, are effective MLK1-3 inhibitors.
• These compounds hold potential for therapeutic applications requiring modulation of MLK signaling pathways.
• Further investigation into the therapeutic utility of these MLK inhibitors is warranted.